As of my last update in January 2022, Iverheal 12 mg, which contains ivermectin as its active ingredient, is primarily used to treat certain parasitic infections in humans, such as onchocerciasis (river blindness) and strongyloidiasis.

However, it's important to note that the use of ivermectin for conditions other than those approved by regulatory authorities (such as the FDA in the United States) may be considered off-label use. Off-label use means using a medication for a purpose other than what it was approved for by the regulatory authorities.

Whether Iverheal 12 mg is covered by insurance would depend on various factors, including the specific insurance plan, the country's regulations, and whether the intended use aligns with approved indications. In some cases, insurance plans may cover off-label use of medications if deemed medically necessary by a healthcare provider.

If you're considering using Iverheal 12 mg and have questions about insurance coverage, it's best to contact your insurance provider directly. They can provide information about coverage options and any requirements for obtaining coverage for off-label use. Additionally, consulting with a healthcare provider can help determine if Iverheal 12 mg is appropriate for your condition and discuss potential insurance coverage options.